Cargando…
HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
As a non-classic major histocompatibility complex (MHC) class I molecule, human leukocyte antigen G (HLA-G) is expressed in fetal-maternal interface and immunoprivileged site only in healthy condition, and in pathological conditions such as cancer, it can be de novo expressed. It is now widely accep...
Autores principales: | Li, Peilong, Wang, Nan, Zhang, Yi, Wang, Chuanxin, Du, Lutao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636042/ https://www.ncbi.nlm.nih.gov/pubmed/34868081 http://dx.doi.org/10.3389/fimmu.2021.791535 |
Ejemplares similares
-
The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology
por: Rebmann, Vera, et al.
Publicado: (2016) -
Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer
por: Mejía-Guarnizo, Lidy Vannessa, et al.
Publicado: (2023) -
The Relationship between the HLA-G Polymorphism and sHLA-G Levels in Parental Pairs with High-Risk Pregnancy
por: Sipak, Olimpia, et al.
Publicado: (2019) -
Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary
por: Schwich, Esther, et al.
Publicado: (2020) -
The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance
por: Hauer, Vanessa, et al.
Publicado: (2019)